Pq. Eichacker et al., LEUKOCYTE CD18 MONOCLONAL-ANTIBODY WORSENS ENDOTOXEMIA AND CARDIOVASCULAR INJURY IN CANINES WITH SEPTIC SHOCK, Journal of applied physiology, 74(4), 1993, pp. 1885-1892
We investigated the effects of a murine monoclonal antibody directed a
gainst the canine leukocyte CD11/18 adhesion complex (MAb R15.7) in a
canine model of septic shock. Awake 2-yr-old purpose-bred beagles were
studied 7 days before and 1, 2, 4, and 10 days after intraperitoneal
placement of an Escherichia coli-infected fibrin clot. Starting 12 h b
efore clot placement, animals received 0.5-1 mg/kg iv every 12 h (4 do
ses total) of either MAb R15.7 (MAb group, n = 8) or, as controls, mur
ine serum protein (n = 8). After infected clot placement, all animals
received antibiotic (ceftriaxone, 100 mg.kg-1.day-1 for 4 days). Two o
f eight control animals and four of eight MAb animals died (P = 0.4).
During the first 8 h after clot placement, MAb animals, compared with
control animals, had greater (P < 0.06) increases in serum endotoxin l
evels and higher (P < 0.05) neutrophil counts. Day 1 after clot placem
ent, MAb animals, compared with control animals, had decreased (P < 0.
05) central venous pressure and arterial pH and increased (P < 0.05) a
rterial lactate. Day 2 after clot placement, MAb animals, compared wit
h control animals, had decreased (P < 0.05) cardiac index and mean art
erial pressure. In summary, MAb R15.7, although associated with increa
sed neutrophil counts, worsened serum endotoxemia, acidosis, and cardi
ovascular function in this canine model of septic shock. These data su
ggest that in septic shock, antibody directed against this leukocyte m
embrane protein complex may be harmful, possibly via impairment of nor
mal leukocyte function.